An observational study in Neuromuscular Diseases, Respiration, Artificial and Tracheostomy, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-02-09.
Sponsored by Centre d'Investigation Clinique et Technologique 805 · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Neuromuscular Diseases by Centre d'Investigation Clinique et Technologique 805 — none open to participants now, none under way, none of them phase 3. Neuromuscular Diseases · Centre d'Investigation Clinique et Technologique 805.
Among the 23 studies in Neuromuscular Diseases by Centre d'Investigation Clinique et Technologique 805, this one is the 4th largest by enrollment of the 10 observational ones that give a count, is the only one that started in 2020, is one of 10 observational ones, and was the 23rd registered.
361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.
Browse Neuromuscular Diseases studies →None of the 23 studies in Neuromuscular Diseases by Centre d'Investigation Clinique et Technologique 805 is open now. The open studies under Neuromuscular Diseases, anywhere →
Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2020.
This study's enrollment of 119 is above the median of 72 across 144 observational studies indexed under Neuromuscular Diseases.
Median enrollment 20 across the 13 interventional studies, 89 across the 10 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 75 studies on the registry; 2 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 23 studies in Neuromuscular Diseases by Centre d'Investigation Clinique et Technologique 805, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims at evaluating the quality of life of patients with slowly progressive neuromuscular disorders who are dependant on mechanical ventilation (daily usage ≥ 16h).
Patients with slowly progressive neuromuscular disease using home mechanical ventilation for at least 16 hours a day since at least one year. Patients may be ventilated via invasive or noninvasive interface.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Score of the Severe Respiratory Insufficiency questionnaire (SRI)
Higher score represents better quality of life
Time frame: 1 Day
Score of the Quality of Life Measure for people with slowly progressive and genetic neuromuscular disease questionnaire (QoL-gNMD)
Higher score represents better quality of life
Time frame: 1 Day
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2020 to primary completion in Dec 2021, 12 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre d'Investigation Clinique et Technologique 805